We had a terrific year 2015. It was the year in which we got serious about the clinical testing market. We successfully continued on the path of attracting more referenceable clients such as University of Iowa, Baby Genes, Prevention Genetics and many more. We rounded out our VarSeq suite by adding more clinically relevant features and of course by adding VSPipeline and VSReports. 2015 was the year in which we put Golden Helix on the map as a true market leader in the clinical analytics space. With our products, patients are being diagnosed for cancer and for hereditary diseases. We are on the front line of Precision Medicine.
Why is it preferable for testing labs to do business with us? Read the full story on Our 2 SNPs… here.